Byung Tae Choi Selected Research

Stroke (Strokes)

1/2024	Therapeutic effects of a novel electrode for transcranial direct current stimulation in ischemic stroke mice.
12/2022	Therapeutic Potential of Active Components from Acorus gramineus and Acorus tatarinowii in Neurological Disorders and Their Application in Korean Medicine.
1/2022	Benefits of a Skull-Interfaced Flexible and Implantable Multilight Emitting Diode Array for Photobiomodulation in Ischemic Stroke.
1/2020	Contralesional Application of Transcranial Direct Current Stimulation on Functional Improvement in Ischemic Stroke Mice.
1/2020	AIM2 inflammasome contributes to brain injury and chronic post-stroke cognitive impairment in mice.
12/2018	Positive effects of α-asarone on transplanted neural progenitor cells in a murine model of ischemic stroke.
12/2017	Low-level light emitting diode therapy promotes long-term functional recovery after experimental stroke in mice.
11/2017	Low-level light emitting diode (LED) therapy suppresses inflammasome-mediated brain damage in experimental ischemic stroke.
3/2016	Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke.
1/2015	Studies on the animal model of post-stroke depression and application of antipsychotic aripiprazole.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Byung Tae Choi Research Topics

Disease

20	Neoplasms (Cancer) 07/2022 - 12/2002
19	Ischemic Stroke 01/2024 - 01/2013
15	Stroke (Strokes) 01/2024 - 08/2011
14	Infarction (Infarctions) 01/2024 - 08/2011
12	Brain Ischemia (Cerebral Ischemia) 07/2022 - 08/2011
11	Ischemia 10/2020 - 01/2014
11	Leukemia 08/2013 - 06/2005
10	Brain Injuries (Brain Injury) 01/2020 - 09/2014
8	Carcinoma (Carcinomatosis) 03/2013 - 12/2002
7	Cognitive Dysfunction 01/2022 - 05/2011
7	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 08/2011
7	Hypoxia (Hypoxemia) 10/2020 - 03/2011
4	Brain Diseases (Brain Disorder) 01/2024 - 01/2014
4	Melanoma (Melanoma, Malignant) 01/2020 - 10/2010
3	Parkinson Disease (Parkinson's Disease) 12/2022 - 01/2020
3	Alzheimer Disease (Alzheimer's Disease) 12/2022 - 06/2006
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 09/2007
3	Cerebral Palsy (Spastic Diplegia) 01/2018 - 05/2017
3	Neuroinflammatory Diseases 08/2016 - 01/2015
3	Hypercholesterolemia 09/2014 - 08/2011
3	Mitochondrial Diseases (Mitochondrial Disease) 03/2009 - 11/2007
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2020 - 03/2013
2	Amyloid Plaque 01/2020 - 06/2006
2	Demyelinating Diseases (Demyelinating Disease) 01/2018 - 11/2015
2	Brain Edema (Cerebral Edema) 03/2016 - 05/2015
2	Edema (Dropsy) 01/2016 - 01/2014
2	Atherosclerosis 09/2014 - 08/2011
2	Necrosis 03/2011 - 05/2006
2	Hepatocellular Carcinoma (Hepatoma) 01/2006 - 05/2004
1	Epilepsy (Aura) 12/2022
1	Nervous System Diseases (Neurological Disorders) 12/2022

Drug/Important Bio-Agent (IBA)

10	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2022 - 01/2013
8	Caspase 3 (Caspase-3)IBA 01/2019 - 11/2003
6	Therapeutic UsesIBA 01/2024 - 01/2020
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2008
5	Cilostazol (Pletal)FDA LinkGeneric 02/2017 - 05/2011
5	CaspasesIBA 08/2013 - 06/2005
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2017 - 08/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2015 - 11/2008
3	Nerve Growth Factors (Neurotrophins)IBA 07/2022 - 01/2020
3	InflammasomesIBA 01/2022 - 11/2017
3	Amyloid (Amyloid Fibrils)IBA 01/2020 - 03/2013
3	Aripiprazole (Abilify)FDA Link 01/2018 - 01/2015
3	AntioxidantsIBA 08/2016 - 05/2006
3	Probucol (Lorelco)FDA Link 08/2016 - 08/2011
3	Neuroprotective AgentsIBA 07/2016 - 01/2011
3	LipopolysaccharidesIBA 01/2015 - 05/2004
3	Monophenol Monooxygenase (Tyrosinase)IBA 05/2012 - 10/2010
3	Melanins (Melanin)IBA 05/2012 - 10/2010
3	DNA (Deoxyribonucleic Acid)IBA 03/2008 - 10/2004
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2006 - 06/2005
2	asaroneIBA 12/2022 - 12/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2022 - 01/2020
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 05/2022 - 01/2020
2	linderalactoneIBA 01/2020 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2014
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 12/2017
2	Amyloid beta-PeptidesIBA 01/2020 - 06/2006
2	Phosphotransferases (Kinase)IBA 01/2019 - 12/2008
2	Oxygen (Dioxygen)IBA 01/2018 - 03/2013
2	Apolipoproteins E (ApoE)IBA 08/2016 - 08/2011
2	LipidsIBA 08/2016 - 09/2014
2	Glutamic Acid (Glutamate)FDA Link 07/2016 - 06/2015
2	Evans Blue (Blue, Evans)FDA Link 03/2016 - 05/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015 - 11/2007
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2015 - 09/2014
2	Peptide Hydrolases (Proteases)FDA Link 11/2015 - 06/2005
2	CytokinesIBA 01/2015 - 03/2011
2	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 10/2011 - 03/2008
2	naringeninIBA 02/2011 - 03/2009
2	esculetinIBA 12/2008 - 03/2008
2	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2008 - 05/2005
2	CurcuminIBA 09/2007 - 05/2006
2	ResveratrolIBA 06/2006 - 02/2004
2	beta-lapachoneIBA 01/2006 - 11/2003
2	quinone (benzoquinone)IBA 01/2006 - 11/2003
2	Alkylating AgentsIBA 06/2005 - 10/2004
2	Methylnitronitrosoguanidine (MNNG)IBA 06/2005 - 10/2004
2	NF-kappa B (NF-kB)IBA 05/2004 - 11/2003
1	N-Methylaspartate (NMDA)IBA 01/2024
1	Sterol Regulatory Element Binding Protein 1IBA 01/2024
1	tenuigeninIBA 12/2023
1	AntigensIBA 07/2022
1	Neurotrophin 3IBA 07/2022
1	EdaravoneIBA 07/2022
1	Free Radical ScavengersIBA 07/2022
1	phytobacteriomycin (PBM)IBA 01/2022
1	InterleukinsIBA 01/2020
1	N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketoneIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Insulysin (Insulin-Degrading Enzyme)IBA 01/2020

Therapy/Procedure

16	Electroacupuncture 12/2023 - 02/2012
16	Therapeutics 07/2022 - 08/2011
4	Transcranial Direct Current Stimulation 01/2024 - 01/2020
4	Acupuncture Points (Acupuncture Point) 07/2022 - 01/2014
3	Low-Level Light Therapy (LLLT) 01/2022 - 01/2016
2	Transplantation 12/2023 - 12/2018
2	East Asian Traditional Medicine (Oriental Medicine) 06/2005 - 05/2004
1	Electrodes (Electrode) 01/2024